TrialBone marrow transplantation2021

Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study.

Kazuhiro Ikegame et al.PubMed ↗Publisher ↗

No numbers read from the abstract.